| BCBS Federal Medical & Drug | 5.21.102 Mylotarg (gemtuzumab ozogamicin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.103 Aliqopa (copanlisib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.104 Verzenio (abemaciclib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.105 Yescarta (axicabtagene ciloleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.106 Calquence (acalabrutinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.108 Erleada (apalutamide) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.110 Braftovi (encorafenib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.112 Tibsovo (ivosidenib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.113 Azedra (iobenguane I 131) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.114 Poteligeo (mogamulizumab-kpkc) | 2026-03-06 |